Home Biosimilar Antibodies Endocrinology & Hormones Others Evinacumab(anti-ANGPTL3) For research use only.
Not for use in humans.

Evinacumab(anti-ANGPTL3)

Evinacumab is a monoclonal antibody that targets, binds to, and pharmacologically inhibits ANGPTL3, which can act as a complementary agent to other LDL-C lowering regimens for patients aged 12 or older with HoFH.

Evinacumab(anti-ANGPTL3)

1 Customer Review

Purity & Quality Control

Batch: Purity: 98% Protein concentration: 6.5mg/ml Endotoxin Level: ＜1EU/mg
98

Biological Activity

Description Evinacumab is a monoclonal antibody that targets, binds to, and pharmacologically inhibits ANGPTL3, which can act as a complementary agent to other LDL-C lowering regimens for patients aged 12 or older with HoFH.

Product Details

CAS No. 1446419-85-7
Molecular Weight 150 kDa
Isotype human IGg1, λ
Application Evinacumab(anti-ANGPTL3)
Source CHO
Purification Protein G
Sterility 0.2 μM filtered
Formulation PBS Buffer, PH 7.4
Storage
(From the date of receipt)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Evinacumab(anti-ANGPTL3) | Evinacumab(anti-ANGPTL3) supplier | purchase Evinacumab(anti-ANGPTL3) | Evinacumab(anti-ANGPTL3) cost | Evinacumab(anti-ANGPTL3) manufacturer | order Evinacumab(anti-ANGPTL3) | Evinacumab(anti-ANGPTL3) distributor